+ Watch SGMO
on My Watchlist
The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.
Sangamo. The very name brings bile to my throat and sets an artery to throbbing in my temple. Much like the name Alamo might to a Texan. I knew this company was crap. I knew zinc fingers were bull. But I wanted to play them like a fish, letting them out and reeling them in, until score leadership was mine. They hit a low point and I green thumbed them. I never thought the losers couldn't even spin a single positive phase II trial. Now I'm just going to forget about this underperform until they go bankrupt. Even if it takes ten years.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions